https://doi.org/10.4081/itjm.2007.1.29

Cholestatic hepatitis induced by atorvastatin: a case-report

Vol. 1 No. 1 (2007)
Submitted: 3 May 2013
Accepted: 3 May 2013
Published: 3 May 2013
Statins, Cholestatic hepatitis, Drug safety.
Abstract Views: 777
PDF: 2196
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M. Vergura
paola.granata@pagepress.org
P. Tomaiuolo
Statins are very well recognized drugs for the management of hypercholesterolaemia and cardiovascular risk. Usually they are very well tolerated with few side effects. We report a case of 77 old years man who developed a cholestatic hepatitis secondary to atorvastatin therapy. The post-marketing surveillance is decisive to valuate the drug safety.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Vergura, M., & Tomaiuolo, P. (2013). Cholestatic hepatitis induced by atorvastatin: a case-report. Italian Journal of Medicine, 1(1), 29–31. https://doi.org/10.4081/itjm.2007.1.29

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.